Show simple item record

dc.contributor.authorBaird, RDen_US
dc.contributor.authorSandhu, Sen_US
dc.contributor.authorYap, Ten_US
dc.contributor.authorMassard, Cen_US
dc.contributor.authorPapadatos-Pastos, Den_US
dc.contributor.authorOlmos, Den_US
dc.contributor.authorDukes, Jen_US
dc.contributor.authorGrainger, Pen_US
dc.contributor.authorPope, Len_US
dc.contributor.authorDe Bono, Jen_US
dc.coverage.spatialBrussels, BELGIUMen_US
dc.date.accessioned2018-06-26T10:50:22Z
dc.date.issued2011-05-01en_US
dc.identifierhttp://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290610100066&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=d4b848928d1c3e5c86d298abb68475f9en_US
dc.identifier.citationANNALS OF ONCOLOGY, 2011, 22 pp. 41 - 41 (1)en_US
dc.identifier.issn0923-7534en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/1936
dc.format.extent41 - 41 (1)en_US
dc.languageEnglishen_US
dc.language.isoEnglishen_US
dc.publisherOXFORD UNIV PRESSen_US
dc.subjectScience & Technologyen_US
dc.subjectLife Sciences & Biomedicineen_US
dc.subjectOncologyen_US
dc.titleBASELINE CIRCULATING TUMOR CELL COUNTS SIGNIFICANTLY ENHANCE A PROGNOSTIC SCORE FOR PATIENTS PARTICIPATING IN PHASE I ONCOLOGY TRIALSen_US
dc.typeOther
rioxxterms.licenseref.startdate2011-05-01en_US
rioxxterms.typeotheren_US
dc.relation.isPartOfANNALS OF ONCOLOGYen_US
pubs.finish-date2011-05-07en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Therapeutics/Medicine Drug Development Unit (de Bono)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Medicine Drug Development Unit (de Bono)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Prostate Cancer Targeted Therapy Group
pubs.publication-statusPublisheden_US
pubs.start-date2011-05-05en_US
pubs.volume22en_US
pubs.embargo.termsNot knownen_US
icr.researchteamMedicine Drug Development Unit (de Bono)en_US
icr.researchteamProstate Cancer Targeted Therapy Groupen_US
dc.contributor.icrauthorDe Bono, Johannen_US
dc.contributor.icrauthorYap, Timothyen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record